目的探讨纤溶酶原激活抑制物-1(PAI-1)基因46/56多态性与儿童青少年血糖及其相关指标的关系。方法选取北京市3919名7~18岁儿童青少年进行身体测量和FPG水平检测,部分样本检测Fins水平。利用基质支持的激光释放/电离飞行时间质谱分析(MALI)I-TDFMS)对PAI-1基因4G/5G多态性进行检测。采用多元线性回归和Logistic二元回归分析基因多态性与血糖及相关指标的关系。结果校正研究人群、年龄和性别后发现,与5G5G基因型比较,4G等位基因携带者FPG水平较高(|9=0.064,SE=0.029,P=0.025)。4G/5G多态性与IFG有相关性(OR=1.640,95%CI:1.1662.309,P=0.005)。校正BMI后该多态性与IFG的相关性没有变化(FPG:β=0.063,SE=0.029,P=0.029;IFG:OR=1.628,95%CI:1.155-2.293,P=0.005)。结论PAI基因4G/5G多态性与儿童青少年血糖水平和IFG有相关性,其效应独立于BMI的作用。
Objective To explore the relationship between 4G/5G polyrnorphism in PAI-1 (plasminogen activator inhibitor-1) gene with blood glucose and glucose-related phenotypes in children and adolescents. Methods Total 3,919 children and adolescents aged 7 - 18 years were recruited. Anthropometric measurements and fasting blood glucose (FPG) detection were performed. Fasting insulin levels in a subgroup were detected. The matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) was used to genotype 4G/SG polymorphism. Linear and logistic regressions were used to analyze the relationship between 4G/SG polymorphism and glucose and related phenotypes. Results Compared with 5G5G genotype,4G allele (4GSG and 4G4G) carriers had higher FPG, after adjustment for age, sex and study population (β= 0. 064, SE= 0. 029, P = 0. 025). 4G/SG polymorphism was associated with risk of impaired fasting glucose (IFG) (OR= 1. 640,95 % CI: 1. 166 2. 309,P=0. 005). The above correlation remained unchanged after further adjustment for body mass index (BMI) (fasting g[ucose..fl=0, 063,SE=0. 029,P=0. 029; IFG:OR=1. 628,95%CI:1. 155-2. 293, P= 0. 005 ). Conclusion 4G/SG polymorphism in PAI-1 gene is associated with FPG and IFG in children and adolescents with its effect independent of BMI.